BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19428103)

  • 21. Low number of DNA copy number changes in small lymphocytic lymphoma.
    Autio K; Aalto Y; Franssila K; Elonen E; Joensuu H; Knuutila S
    Haematologica; 1998 Aug; 83(8):690-2. PubMed ID: 9793251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis.
    Matthews C; Catherwood MA; Morris TC; Alexander HD
    Leuk Res; 2007 Feb; 31(2):231-4. PubMed ID: 16714060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical and biological features of a series of immunophenotypic variant of B-CLL.
    Cro L; Ferrario A; Lionetti M; Bertoni F; Zucal N N; Nobili L; Fabris S; Todoerti K; Cortelezzi A; Guffanti A; Goldaniga M; Marcheselli L; Neri A; Lambertenghi-Deliliers G; Baldini L
    Eur J Haematol; 2010 Aug; 85(2):120-9. PubMed ID: 20408870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
    Quintero-Rivera F; Nooraie F; Rao PN
    Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types.
    Bahler DW; Aguilera NS; Chen CC; Abbondanzo SL; Swerdlow SH
    Am J Pathol; 2000 Oct; 157(4):1063-70. PubMed ID: 11021809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator.
    Sahota SS; Babbage G; Zojer N; Ottensmeier CH; Stevenson FK
    Methods Mol Med; 2005; 115():129-44. PubMed ID: 15998966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
    Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
    Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ; Parrish RS; Schichman SA; Zent CS
    Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
    Smolej L; Andrys C; Peková S; Schwarz J; Belada D; Zák P
    Haematologica; 2006 Oct; 91(10):1432-3. PubMed ID: 17018398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
    Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia.
    Berkova A; Pavlistova L; Babicka L; Houskova L; Tajtlova J; Balazi P; Cmunt E; Schwarz J; Karban J; Trneny M; Brezinova J; Zemanova Z; Michalova K
    Neoplasma; 2008; 55(5):400-8. PubMed ID: 18665750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
    Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
    Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia.
    Koiso H; Yamane A; Mitsui T; Matsushima T; Tsukamoto N; Murakami H; Miyawaki S; Nojima Y; Karasawa M
    Leuk Res; 2006 Mar; 30(3):272-6. PubMed ID: 16159662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Karyotype complexity and VH gene status in B-cell chronic lymphocytic leukemia.
    Méhes G; Kovács G; Kajtár B; Lacza A; Várnai A; Losonczy H; Pajor L
    Haematologica; 2006 Oct; 91(10):1430-1. PubMed ID: 16963400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.